| Dr Gary Walter Upchurch, OD | |
|
127 Foothills Ave Ste 3, Albany, KY 42602-1037 | |
| (606) 387-5612 | |
| (606) 387-6602 |
| Full Name | Dr Gary Walter Upchurch |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 44 Years |
| Location | 127 Foothills Ave Ste 3, Albany, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265433478 | NPI | - | NPPES |
| 01047034 | Other | AMERIGROUP | |
| 4599126 | Medicaid | TN | |
| 4627 | Other | KY | AVESIS/MEDICAID |
| 3068022 | Other | BCBSTN/BLUECARE/TENNCARE | |
| 7100209970 | Medicaid | KY | |
| 77009298 | Medicaid | KY | |
| 410003588 | Other | KY | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OD2197 (Tennessee) | Secondary |
| 152W00000X | Optometrist | 929DT (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Eye Care Inc | 7012908643 | 11 |
| Associates In Eye Care Inc | 7012908643 | 11 |
News Archive
Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Imagine being able to detect Alzheimer's disease at its earliest stage and prescribe the proper medication to halt its progress. Imagine being able to evaluate the health of heart muscles and tissues after an attack and accurately prescribe treatment to prevent future heart failure. London is close to making these possibilities a reality with the installation of Canada's first whole body PET/MRI scanner at St. Joseph's Hospital, part of St. Joseph's Health Care London.
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26% of patients undergoing pulmonary resection for non-small-cell lung cancer.
A new study released today reveals that adolescents who use e cigarettes may be at a greater risk of using addictive substances instead of regular flavouring. The study was published today in the latest issue of the journal American Journal of Preventive Medicine.
› Verified 4 days ago
| Provider Name | Associates In Eye Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649377177 PECOS PAC ID: 7012908643 Enrollment ID: O20050513000284 |
News Archive
Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Imagine being able to detect Alzheimer's disease at its earliest stage and prescribe the proper medication to halt its progress. Imagine being able to evaluate the health of heart muscles and tissues after an attack and accurately prescribe treatment to prevent future heart failure. London is close to making these possibilities a reality with the installation of Canada's first whole body PET/MRI scanner at St. Joseph's Hospital, part of St. Joseph's Health Care London.
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26% of patients undergoing pulmonary resection for non-small-cell lung cancer.
A new study released today reveals that adolescents who use e cigarettes may be at a greater risk of using addictive substances instead of regular flavouring. The study was published today in the latest issue of the journal American Journal of Preventive Medicine.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gary Walter Upchurch, OD Po Box 306, Ferguson, KY 42533-0306 Ph: (606) 492-2211 | Dr Gary Walter Upchurch, OD 127 Foothills Ave Ste 3, Albany, KY 42602-1037 Ph: (606) 387-5612 |
News Archive
Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Imagine being able to detect Alzheimer's disease at its earliest stage and prescribe the proper medication to halt its progress. Imagine being able to evaluate the health of heart muscles and tissues after an attack and accurately prescribe treatment to prevent future heart failure. London is close to making these possibilities a reality with the installation of Canada's first whole body PET/MRI scanner at St. Joseph's Hospital, part of St. Joseph's Health Care London.
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26% of patients undergoing pulmonary resection for non-small-cell lung cancer.
A new study released today reveals that adolescents who use e cigarettes may be at a greater risk of using addictive substances instead of regular flavouring. The study was published today in the latest issue of the journal American Journal of Preventive Medicine.
› Verified 4 days ago
Vision Care Of Albany Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 256 Burkesville Rd, Albany, KY 42602 Phone: 606-307-2732 | |
Associates In Eye Care, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 127 Foothills Ave, Suite 3, Albany, KY 42602 Phone: 606-387-5612 Fax: 606-387-6602 |